Skip to main content
Clinical Trials/JPRN-UMIN000039101
JPRN-UMIN000039101
Completed
未知

The anesthesia management with remifentanil uses partial antagonist effect of pentazocine for mu opioid receptor - The anesthesia management with remifentanil uses partial antagonist effect of pentazocine for mu opioid receptor

Matsudo city general hospital Anesthesiology0 sites10 target enrollmentJanuary 10, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients undergoing general anesthesia
Sponsor
Matsudo city general hospital Anesthesiology
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 10, 2020
End Date
April 30, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Matsudo city general hospital Anesthesiology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • ASA\-PS \>\=3 Tha patients who are diagnosised or suspected sleep apnea syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials